drug

MK-2214

Phase 2updated 3mo ago

by $MRK Merck & Co., Inc.

Phase 2

community read0 votes

indications

Alzheimer's Disease

all catalysts(0)

nothing on the calendar yet

Trials studying MK-2214

phase2A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)recruitingn=340
phase1A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)completedn=34

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed just now

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

MK-2214

Phase 2updated 3mo ago

by $MRK Merck & Co., Inc.

Phase 2

community read0 votes

indications

Alzheimer's Disease

all catalysts(0)

nothing on the calendar yet

Trials studying MK-2214

phase2A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)recruitingn=340
phase1A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)completedn=34

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed just now

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

MK-2214

indications

all catalysts(0)

Trials studying MK-2214

News(0)

Report a data issue

comments(0)

MK-2214

indications

all catalysts(0)

Trials studying MK-2214

News(0)

Report a data issue

comments(0)